Company Dashboard
Explore stock charts, earnings, outlooks, and dividends for any company.
Regeneron Pharmaceuticals, Inc. ( NASDAQ : REGN )
| Pre-Market | Intra-Day | After-Hours |
|---|---|---|
|
—
|
799.65
(
-5.37
/
-0.67%
)
|
—
|
| — | 26-Oct 12:09 | 22-Oct 15:59 |
| Previous Close | 805.02 | 52-Week Low | 575.93 |
| Open | 812.50 | 52-Week High | 859.34 |
| Day Low | 798.74 | 50-Day Average | 789.57 |
| Day High | 816.78 | 200-Day Average | 735.29 |
| Volume | 8.13 K | Market Cap | 80.19 B |
REGN Earnings Calendar
Earnings reports, estimates, results and year-over-year growth for REGN.
Showing
1 –
5
of
5
earnings records
from
2025-10-28
to
2026-10-30
| Symbol | Date | Time | Period | Metric | Actual | Estimate | Prior Year | Surprise | Growth | News |
|---|---|---|---|---|---|---|---|---|---|---|
|
|
2026-10-30 | BMO | Q3 2026 | EPS | — | $15.99 | $11.83 | — | — | — |
| REV | — | $4.54 B | $3.75 B | — | — | |||||
|
|
2026-07-30 | BMO | Q2 2026 | EPS | $14.29 | $10.26 | $12.89 | Beat (+39.28%) | Up (+10.86%) | View |
| REV | $4.29 B | $3.82 B | $3.68 B | Beat (+12.30%) | Up (+16.58%) | |||||
|
|
2026-04-29 | BMO | Q1 2026 | EPS | $9.47 | $8.89 | $8.22 | Beat (+6.52%) | Up (+15.21%) | View |
| REV | $3.61 B | $3.48 B | $3.03 B | Beat (+3.74%) | Up (+19.14%) | |||||
|
|
2026-01-30 | BMO | Q4 2025 | EPS | $11.44 | $10.71 | $12.07 | Beat (+6.82%) | Down (-5.22%) | View |
| REV | $3.88 B | $3.77 B | $3.79 B | Beat (+2.92%) | Up (+2.37%) | |||||
|
|
2025-10-28 | BMO | Q3 2025 | EPS | $11.83 | $9.59 | $12.46 | Beat (+23.36%) | Down (-5.06%) | View |
| REV | $3.75 B | $3.59 B | $3.72 B | Beat (+4.46%) | Up (+0.81%) |
Sign up to see MORE data
Create your FREE CatalystPICR account to access additional company data.
Sign Up Free